References
- Antoniou, M., C. V. H. Mem Habib, R. C. Jennings, C. Leifert, and J. Fagan. 2012. “Teratogenic Effects of Glyphosate-Based Herbicides: Divergence of Regulatory Decisions from Scientific Evidence.” Journal of Environmental & Analytical Toxicology 1 (S4): S4. https://doi.org/10.4172/2161-0525.s4-006.
- Bacon, M.-H., L. Vandelac, M.-A. Gagnon, and L. Parent. 2023. “Poisoning Regulation, Research, Health, and the Environment: The Glyphosate-Based Herbicides Case in Canada.” Toxics 11 (2): 121. https://doi.org/10.3390/toxics11020121.
- Cambridge Dictionary. “Ghostwriting.” 2023. In https://dictionary.cambridge.org/dictionary/english/ghostwriting.
- CBD (Centre for Biological Diversity). 2018. “Retraction Letter to Critical Reviews in Toxicology.” https://www.biologicaldiversity.org/campaigns/pesticides_reduction/pdfs/Retraction_letter_to_Critical_Reviews_in_Toxicology.pdf.
- Chang, E. T., and E. Delzell. 2016. “Systematic Review and Meta-Analysis of Glyphosate Exposure and Risk of Lymphohematopoietic Cancers.” Journal of Environmental Science and Health Part B-Pesticides Food Contaminants and Agricultural Wastes 51 (6): 402–434. https://doi.org/10.1080/03601234.2016.1142748.
- Coe, R. A. J., and RTP (Regulatory Toxicology and Pharmacology). 2000. “Instructions to Authors.” Regulatory Toxicology and Pharmacology 31 (2): S1–S3. https://doi.org/10.1006/rtph.2000.1379.
- CRT. 2018a. “Corrigendum.” Critical Reviews in Toxicology 48 (10): 893–894. 2018 ‘Combined’ article. https://doi.org/10.1080/10408444.2018.1522175.
- CRT. 2018b. “Corrigendum.” Critical Reviews in Toxicology 48 (10): 898. 2018 Acquavella et al ‘epidemiology’ article. https://doi.org/10.1080/10408444.2018.1522142.
- CRT. 2018c. “Corrigendum.” Critical Reviews in Toxicology 48 (10): 900. 2018 Williams et al ‘rodent carcinogenicity’. https://doi.org/10.1080/10408444.2018.1522784.
- CRT. 2018d. “Corrigendum.” Critical Reviews in Toxicology 48 (10): 902. 2018 Brusick et al ‘genotoxicity’. https://doi.org/10.1080/10408444.2018.1522133.
- CRT 2018. 2018e. “Expression of Concern– 30 November 2018.” Critical Reviews in Toxicology 48 (10): 903. https://doi.org/10.1080/10408444.2018.1539570.
- CRT (Critical Reviews in Toxicology). 2013. “Reviewers for Critical Reviews in Toxicology – 2013.” Critical Reviews in Toxicology 43 (10): 892–892. https://doi.org/10.3109/10408444.2013.861973.
- DeTora, L. M., M. A. Carey, D. Toroser, and E. Z. Baum. 2019. “Ghostwriting in Biomedicine: A Review of the Published Literature.” Current Medical Research and Opinion 35 (9): 1643–1651. https://doi.org/10.1080/03007995.2019.1608101.
- Elliott, C. 2011. White Coat, Black Hat: Adventures on the Dark Side of Medicine. Boston: Beacon Press.
- Foucart, F., and H. S. European Press Prize. 2018. “Monsanto Papers. European Press Prize Investigative Reporting Award Winner 2018.” https://www.europeanpressprize.com/article/monsanto-papers/.
- Fugh-Berman, A. 2005. “The Corporate Coauthor.” Journal of General Internal Medicine 20 (6): 546–548. https://doi.org/10.1111/j.1525-1497.2005.05857.x.
- Fugh-Berman, A. 2010. “The Haunting of Medical Journals: How Ghostwriting Sold ‘HRT.’.” PLOS Medicine 7 (9): e1000335. https://doi.org/10.1371/journal.pmed.1000335.
- Gillam, C. 2021. Monsanto Papers: Deadly Secrets, Corporate Corruption, and One Man’s Search for Justice. Washington. DC: Island Press.
- Glenna, L., and A. B. Bruce. 2021. “Suborning Science for Profit: Monsanto, Glyphosate, and Private Science Research Misconduct.” Research Policy 50 (7): 104290. https://doi.org/10.1016/j.respol.2021.104290.
- Government of Canada, Interagency Advisory Panel on Responsible Conduct of Research. 2022. “Tri-Agency Framework: Responsible Conduct of Research (2021).” May 18, 2022. https://rcr.ethics.gc.ca/eng/framework-cadre-2021.html.
- Greim, H., D. Saltmiras, V. Mostert, and C. Strupp. 2015. “Evaluation of Carcinogenic Potential of the Herbicide Glyphosate, Drawing on Tumor Incidence Data from Fourteen Chronic/Carcinogenicity Rodent Studies.” Critical Reviews in Toxicology 45 (3): 185–208. https://doi.org/10.3109/10408444.2014.1003423.
- Guyton, K. Z., D. Loomis, Y. Grosse, F. El Ghissassi, L. Benbrahim-Tallaa, N. Guha, C. Scoccianti, H. Mattock, and K. Straif. 2015. “Carcinogenicity of Tetrachlorvinphos, Parathion, Malathion, Diazinon, and Glyphosate.” The Lancet Oncology 16 (5): 490–491. https://doi.org/10.1016/s1470-2045(15)70134-8.
- Healy, D., and D. Cattell. 2003. “Interface Between Authorship, Industry and Science in the Domain of Therapeutics.” British Journal of Psychiatry 183 (1): 22–27. https://doi.org/10.1192/bjp.183.1.22.
- Hirsch, L. J. 2009. “Conflicts of Interest, Authorship, and Disclosures in Industry-Related Scientific Publications: The Tort Bar and Editorial Oversight of Medical Journals.” Mayo Clinic Proceedings 84 (9): 811–821. https://doi.org/10.4065/84.9.811.
- ICMJE (International Committee of Medical Journal Editors). 2023. http://icmje.org.
- Jefferson, T., M. A. Jones, P. Doshi, C. B. Del Mar, R. Hama, M. J. Thompson, E. A. Spencer, I. J. Onakpoya, K. R. Mahtani, D. Nunan, et al. 2014. “Neuraminidase Inhibitors for Preventing and Treating Influenza in Adults and Children.” Cochrane Database of Systematic Reviews 2018(1). https://doi.org/10.1002/14651858.cd008965.pub4.
- JTEH (Journal of Toxicology and Environmental Health). 2012. “Instructions to Authors’.” Journal of Toxicology and Environmental Health, Part B 15 (1).
- Kier, L. D., and D. Kirkland. 2013. “Review of Genotoxicity Studies of Glyphosate and Glyphosate-Based Formulations.” Critical Reviews in Toxicology 43 (4): 283–315. https://doi.org/10.3109/10408444.2013.770820.
- Kimmel, G. L., C. A. Kimmel, A. W. Williams, and J. M. DeSesso. 2013. “Evaluation of Developmental Toxicity Studies of Glyphosate with Attention to Cardiovascular Development.” Critical Reviews in Toxicology 43 (2): 79–95. https://doi.org/10.3109/10408444.2012.749834.
- Krimsky, S., and C. Gillam. 2018. “Roundup Litigation Discovery Documents: Implications for Public Health and Journal Ethics.” Journal of Public Health Policy 39 (3): 318–326. https://doi.org/10.1057/s41271-018-0134-z.
- Lacasse, J. R., J. Leo, A. N. Cimino, K. F. Bean, and M. Del-Colle. 2012. “Knowledge of Undisclosed Corporate Authorship (‘Ghostwriting’) Reduces the Perceived Credibility of Antidepressant Research: A Randomized Vignette Study with Experienced Nurses.” BMC Research Notes 5 (1). https://doi.org/10.1186/1756-0500-5-490.
- Le Noury, J., J. M. Nardo, D. Healy, J. Jureidini, M. Raven, C. Tufanaru, and E. Abi-Jaoude. 2015. “Restoring Study 329: Efficacy and Harms of Paroxetine and Imipramine in Treatment of Major Depression in Adolescence.” BMJ h4320. https://doi.org/10.1136/bmj.h4320.
- Leo, J., J. R. Lacasse, and A. N. Cimino. 2011. “Why Does Academic Medicine Allow Ghostwriting? A Prescription for Reform.” Society 48 (5): 371–375. https://doi.org/10.1007/s12115-011-9455-2.
- Lundh, A., J. Lexchin, B. Mintzes, J. Schroll, and L. Bero. 2017, 2. “Industry Sponsorship and Research Outcome.” Cochrane Library 2017 (2). https://doi.org/10.1002/14651858.mr000033.pub3.
- Matheson, A. 2016a. “The ICMJE Recommendations and Pharmaceutical Marketing – Strengths, Weaknesses and the Unsolved Problem of Attribution in Publication Ethics.” BMC Medical Ethics 17 (1): 1. https://doi.org/10.1186/s12910-016-0103-7.
- Matheson, A. 2016b. “Ghostwriting: The Importance of Definition and Its Place in Contemporary Drug Marketing.” BMJ i4578. https://doi.org/10.1136/bmj.i4578.
- Matheson, A. 2017, 1. “Marketing Trials, Marketing Tricks — How to Spot Them and How to Stop Them.” Trials 18 (1). https://doi.org/10.1186/s13063-017-1827-5.
- Matheson, A. 2022. “Attribution and Credit Bias in Publication Ethics.” Indian Journal of Medical Ethics 7 (3): 204–211. https://doi.org/10.20529/ijme.2022.023.
- McClellan, R. O. 2016. “Evaluating the Potential Carcinogenic Hazard of Glyphosate.” Critical Reviews in Toxicology 46 (sup1): 1–2. https://doi.org/10.1080/10408444.2016.1234117.
- McHenry, L. B. 2018. “The Monsanto Papers: Poisoning the Scientific Well.” International Journal of Risk & Safety in Medicine 29 (3–4): 193–205. https://doi.org/10.3233/jrs-180028.
- McHenry, L. B., and J. N. Jureidini. 2008. “Industry-Sponsored Ghostwriting in Clinical Trial Reporting: A Case Study.” Accountability in Research 15 (3): 152–167. https://doi.org/10.1080/08989620802194384.
- Mink, P. J., J. S. Mandel, B. K. Sceurman, and J. I. Lundin. 2012. “Epidemiologic Studies of Glyphosate and Cancer: A Review.” Regulatory Toxicology and Pharmacology 63 (3): 440–452. https://doi.org/10.1016/j.yrtph.2012.05.012.
- Moffatt, B. 2013. “Orphan Papers and Ghostwriting: The Case Against the ICMJE Criterion of Authorship.” Accountability in Research 20 (2): 59–71. https://doi.org/10.1080/08989621.2013.767115.
- Monsanto Leaks website. 2023a. http://www.monsantoleaks.com/monsanto-documents/72-Document-Details-Monsantos-Goals-After-IARC-Report.pdf.
- Monsanto Leaks website. 2023b. “Monsanto Internal Email.” http://www.monsantoleaks.com/m0nsanto-documents/5-Monsanto-Involvement-with-Scientific-Studies-Without-Disclosing-Conflicts-of-Interest.pdf.
- Morreim, E. H., and C. W. Jeffrey. 2021. “Guest Authorship as Research Misconduct: Definitions and Possible Solutions.” BMJ Evidence-Based Medicine 28 (1): 1–4. https://doi.org/10.1136/bmjebm-2021-111826.
- Ngai, S., J. L. Gold, S. S. Gill, and P. A. Rochon. 2005. “Haunted Manuscripts: Ghost Authorship in the Medical Literature.” Accountability in Research 12 (2): 103–114. https://doi.org/10.1080/08989620590957175.
- Resnik, D. B., A. M. Tyler, J. D. Black, and G. E. Kissling. 2016. “Authorship Policies of Scientific Journals.” Journal of Medical Ethics 42 (3): 199–202. https://doi.org/10.1136/medethics-2015-103171.
- Ross, J. S., K. D. Hill, D. Egilman, and H. M. Krumholz. 2008. “Guest Authorship and Ghostwriting in Publications Related to Rofecoxib.” JAMA 299 (15): 1800. https://doi.org/10.1001/jama.299.15.1800.
- Sismondo, S. 2007. “Ghost Management: How Much of the Medical Literature is Shaped Behind the Scenes by the Pharmaceutical Industry?” PLoS Medicine 4 (9): e286. https://doi.org/10.1371/journal.pmed.0040286.
- Stretton, S. 2014. “Systematic Review on the Primary and Secondary Reporting of the Prevalence of Ghostwriting in the Medical Literature.” British Medical Journal Open 4 (7): e004777–77. https://doi.org/10.1136/bmjopen-2013-004777.
- Thacker, P. 2022. “Monsanto’s Ghostwriting to Influence Science and Media.” Journal of Scientific Practice and Integrity Blog. https://www.jospi.org/post/1492-monsanto-s-ghostwriting-to-influence-science-and-media.
- UCSF. 2023a. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=xhwl0231.
- UCSF. 2023b. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=gxmn0226.
- UCSF. 2023c. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=ptpl0226.
- UCSF. 2023d. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=zkvm0226.
- UCSF. 2023e. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=jhmn0226.
- UCSF. 2023f. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=ffvm0226.
- UCSF. 2023g. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=gpxw0229.
- UCSF. 2023h. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=tzpl0226.
- UCSF. 2023i. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=jpxw0229.
- UCSF. 2023j. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=szpl0226.
- UCSF. 2023k. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=xfvm0226.
- UCSF. 2023l. “UCSF Chemical Industry Documents Home Page.” https://www.industrydocuments.ucsf.edu/chemical.
- UCSF (University of California at San Francisco Chemical Industry Documents). 2023m. “Monsanto Internal Email.” https://www.industrydocuments.ucsf.edu/chemical/docs/#id=qqxw0229.
- UKRIO (UK Research Integrity Office). 2023. ““What is Research Misconduct?” April 2, 2023. https://ukrio.org/about-us/what-is-research-misconduct/.
- USRTK. 2023a. “Monsanto documents.” https://usrtk.org/wp-content/uploads/2019/08/Retraction-email-redacted.pdf.
- USRTK. 2023b. “Monsanto Internal Email.” https://usrtk.org/wp-content/uploads/bsk-pdf-manager/2019/04/Ghostwriting-Monsanto-Email-Congratulating-scientists-for-their-work-on-independent-Williams-Kroes-Munro-article.pdf.
- USRTK. 2023c. “Monsanto Internal Email.” https://usrtk.org/wp-content/uploads/2019/04/Heydens-1999-ghostwriting-email-saying-will-strangle-Williams-if-he-asks-for-rewrites.pdf.
- USRTK. 2023d. “Monsanto Internal Email.” https://usrtk.org/wp-content/uploads/bsk-pdf-manager/2019/04/Donna-Farmer-and-Amy-Williams-Email-Demonstrates-Monsanto-Ghostwrote-Portions-of-Exponent-Manuscript.pdf.
- USRTK. 2023e. “Monsanto Internal Email.” https://usrtk.org/wp-content/uploads/2019/08/June-2018-from-McClellan-to-Whally-defending-authors.pdf.
- USRTK. 2023f. “USRTK Monsanto Papers Home Page.” https://usrtk.org/monsanto-papers/.
- USRTK (US Right to Know website). 2023g. Monsanto Internal Email. https://usrtk.org/wp-content/uploads/2017/08/18-Monsanto-Scientist-Admits-to-Ghostwriting-Cancer-Review-Paper.pdf.
- Vasilevsky, N., M. Hosseini, S. Teplitzky, V. Ilik, E. Mohammadi, J. Schneider, B. Kern, J. Colomb, S. C. Edmunds, K. Gutzman, et al. 2021. “Is Authorship Sufficient for Today’s Collaborative Research? A Call for Contributor Roles.” Accountability in Research 28 (1): 23–43. https://doi.org/10.1080/08989621.2020.1779591.
- Williams, G. M., M. J. Aardema, J. F. Acquavella, C. Berry, D. Brusick, M. M. Burns, J. Lauro Viana De Camargo, D. Garabrant, H. A. Greim, L. D. Kier, et al. 2016. “A Review of the Carcinogenic Potential of Glyphosate by Four Independent Expert Panels and Comparison to the IARC Assessment.” Critical Reviews in Toxicology 46 (sup1): 3–20. https://doi.org/10.1080/10408444.2016.1214677.
- Williams, G. M., R. Kroes, and I. Munro. 2000. “Safety Evaluation and Risk Assessment of the Herbicide Roundup and Its Active Ingredient, Glyphosate, for Humans.” Regulatory Toxicology and Pharmacology 31 (2): 117–165. https://doi.org/10.1006/rtph.1999.1371.
- Williams, A. W., R. Watson, and J. M. DeSesso. 2012. “Developmental and Reproductive Outcomes in Humans and Animals After Glyphosate Exposure: A Critical Analysis.” Journal of Toxicology and Environmental Health-Part B-Critical Reviews 15 (1): 39–96. https://doi.org/10.1080/10937404.2012.632361.
- Wisner Baum, 2019. “Monsanto Executive William Heydens Deposition 1.23.2017 | Pilliod Monsanto Trial.” At 49 minutes. https://www.youtube.com/watch?v=lN9CAWdctjo.
- Wisner Baum,2023a. “Monsanto Internal Email.” https://www.baumhedlundlaw.com/documents/pdf/monsanto-documents-2/mongly00992949-revised-redactions.pdf.
- Wisner Baum,2023b. “Monsanto Internal Email.” https://www.baumhedlundlaw.com/documents/pdf/monsanto-documents/33-monsanto-consultant-you-cant-say-that-there-is-no-evidence-of-roundup-carcinogenicity.pdf.
- Wisner Baum, 2023c. ”Monsanto Internal Email.” https://www.baumhedlundlaw.com/documents/pdf/monsanto-documents-2/mongly02133654-redacted.pdf.
- Wisner Baum,2023d. “Monsanto Internal Email.” https://www.wisnerbaum.com/documents/pdf/monsanto-documents-2/mongly01041641-redacted.pdf.
- Wisner Baum,2023e. “Wisner Baum Monsanto Papers Home Page.” https://www.wisnerbaum.com/toxic-tort-law/monsanto-roundup-lawsuit/monsanto-papers/.